Quarterly report pursuant to Section 13 or 15(d)

12. Stock-based Compensation

v3.8.0.1
12. Stock-based Compensation
6 Months Ended
Mar. 31, 2018
Share-based Compensation [Abstract]  
Stock-based Compensation

From time to time, the Company grants stock options and restricted stock awards to directors, officers and employees. These awards are valued at the grant date by determining the fair value of the instruments, net of estimated forfeitures. The value of each award is amortized on a straight-line basis over the requisite service period.

 

Stock Options

 

The following table summarizes stock option activity for the six months ended March 31, 2018:

 

          Weighted     Weighted        
          Average     Average        
    Number of     Exercise     Remaining        
    Shares     Price     Contractual Life     Intrinsic Value  
Outstanding at September 30, 2017     211,668     $ 13.19       3.47     $ 454,417  
Granted     20,000       32.24       10.00          
Exercised                              
Forfeited                              
Outstanding at March 31, 2018     231,668     $ 14.84       3.54     $ 429,417  
Exercisable at March 31, 2018     187,167     $ 11.75       2.58     $ 429,417  

 

The Company recognized compensation expense of $60,829 and $68,084 during the three months ended March 31, 2018 and 2017, respectively. The Company recognized compensation expense of $140,185 and $69,520 during the six months ended March 31, 2018 and 2017, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, net of estimated forfeitures.

  

At March 31, 2018, the Company has $385,179 of unrecognized compensation expense (net of estimated forfeitures) associated with stock option awards which the company expects to recognize as compensation expense through October of 2022.

 

The exercise price for stock options outstanding and exercisable outstanding at March 31, 2018 is as follows:

 

Outstanding     Exercisable  
Number of     Exercise     Number of     Exercise  
Options     Price     Options     Price  
  31,250     $ 5.00       31,250     $ 5.00  
  25,000       7.50       25,000       7.50  
  31,250       10.00       31,250       10.00  
  4,167       10.86       4,167       10.86  
  4,167       10.86                  
  4,167       10.86                  
  4,167       10.86                  
  6,250       12.50       6,250       12.50  
  6,250       15.00       6,250       15.00  
  75,000       15.18       75,000       15.18  
  8,000       23.41       8,000       15.18  
  8,000       27.60                  
  8,000       31.74                  
  8,000       36.50                  
  8,000       41.98                  
  231,668               187,167          

 

 

The following table summarizes information about the Company’s non-vested shares outstanding as of March 31, 2018:

 

          Weighted  
          Average  
    Number of     Grant-Date  
Non-vested Shares   Shares     Fair Value  
Non-vested at September 30, 2017     36,668     $ 17.70  
Granted     20,000     $ 10.14  
Vested     (12,167 )   $ 13.32  
Non-vested at March 31, 2018     44,501     $ 13.54  

 

Options were granted during fiscal 2017 and 2016, where the exercise price was less than the common stock price at the date of  grant or where the exercise price was greater than the common stock price at the date of grant. There have been no options granted in fiscal 2018 to date. The assumptions used in calculating the fair value of stock options granted use the Black-Scholes option pricing model for options granted were as follows:

 

Risk-free interest rate   1.25%
Expected life of the options   5.0 to 10.0 years
Expected volatility   107%
Expected dividend yield   0%